Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2003 1
2004 2
2005 1
2006 4
2007 1
2008 2
2009 4
2010 1
2012 1
2013 2
2014 2
2015 1
2016 1
2017 2
2018 1
2019 3
2020 2
2021 2
2022 1
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Chlamydomonas proteomics.
Rolland N, Atteia A, Decottignies P, Garin J, Hippler M, Kreimer G, Lemaire SD, Mittag M, Wagner V. Rolland N, et al. Among authors: wagner v. Curr Opin Microbiol. 2009 Jun;12(3):285-91. doi: 10.1016/j.mib.2009.04.001. Epub 2009 May 18. Curr Opin Microbiol. 2009. PMID: 19451016 Review.
Targeted thorium-227 conjugates as treatment options in oncology.
Karlsson J, Schatz CA, Wengner AM, Hammer S, Scholz A, Cuthbertson A, Wagner V, Hennekes H, Jardine V, Hagemann UB. Karlsson J, et al. Among authors: wagner v. Front Med (Lausanne). 2023 Jan 9;9:1071086. doi: 10.3389/fmed.2022.1071086. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36726355 Free PMC article. Review.
The emerging nanomedicine landscape.
Wagner V, Dullaart A, Bock AK, Zweck A. Wagner V, et al. Nat Biotechnol. 2006 Oct;24(10):1211-7. doi: 10.1038/nbt1006-1211. Nat Biotechnol. 2006. PMID: 17033654 No abstract available.
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials.
Rugo HS, Van Poznak CH, Neven P, Danielewicz I, Lee SC, Campone M, Chik JYK, Vega Alonso E, Naume B, Brain E, Siegel JM, Li R, Uema D, Wagner VJ, Coleman RE. Rugo HS, et al. Among authors: wagner vj. Breast Cancer Res Treat. 2024 Apr;204(2):249-259. doi: 10.1007/s10549-023-07147-z. Epub 2023 Dec 20. Breast Cancer Res Treat. 2024. PMID: 38123789 Free PMC article. Clinical Trial.
36 results